Skip to content

Comparison of ART Outcomes in Repeat Gonadotrophin-releasing Hormone Agonist Trigger Versus Single Dose Agonist Trigger in PCOS Patients Undergoing IVF/ICSI

Comparison of ART Outcomes in Repeat Gonadotrophin-releasing Hormone Agonist Trigger Versus Single Dose Agonist Trigger in PCOS Patients Undergoing IVF/ICSI:A Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105106
Enrollment
60
Registered
2026-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Repeat dose of GnRh agonist trigger: A repeat-dose GnRH agonist trigger given in PCOS patients undergoing IVF cycles with GnRH antagonist protocol Control Intervention1: Single dose of

Sponsors

Jhalak Jain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All women between the age 21-38 years, satisfying diagnostic criteria of PCOS according to ESHRE(2018)criteria which defines: Any 2 of 3 1.Irregular menstrual cycles and anovulation 2.Clinical or biochemical signs of hyperandrogenism 3.Polycystic ovarian morphology after excluding other disorders with similar clinical presentation

Exclusion criteria

Exclusion criteria: Other causes of anovulation/irregular menses-Hypothyroid, Hyperprolactinemia, Premature Ovarian Insufficiency Other causes of hyperandrogenemia like late onset Congenital Adrenal Hyperplasia, Cushing s Syndrome.

Design outcomes

Primary

MeasureTime frame
total oocytes retrieved and no. of mature oocytes retrievedTimepoint: 48 hours After ovum pickup

Secondary

MeasureTime frame
hormonal parameters (LH) at 12 hours post first trigger, oocyte maturity rate , number of top-quality embryos (day 3) & blastocysts (day 5), incidence of OHSS (if any) , clinical pregnancy rates following frozen embryo transferTimepoint: Till 4weeks post transfer

Countries

India

Contacts

Public ContactJhalak Jain

Indira Gandhi Institute of medical sciences

jhalakjn96@gmail.com8447022568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026